tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $92.03. This is a potential upside of $64.43 (233.44%) from yesterday's end of day stock price of $27.6.
Aeglea Bio Therapeutics's activity chart (see below) currently has 16 price targets and 27 ratings on display.
Analysts average stock forecasts to be materialized ratio is 51.19% with an average time for these price targets to be met of 236.57 days.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 12-Nov-2023. First documented stock forecast 08-May-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$12
$-15.6 (-56.52%)
1 years 11 months ago
(12-Nov-2023)
2/2 (100%)
$1.82 (17.88%)
14
Buy
$23
$-4.6 (-16.67%)
$22.5
2 years 1 months 2 days ago
(10-Sep-2023)
2/2 (100%)
$8.95 (63.70%)
141
Hold
$25
$-2.6 (-9.42%)
2 years 7 months 10 days ago
(02-Mar-2023)
1/3 (33.33%)
$15.15 (153.81%)
325
Hold
$25
2 years 11 months 16 days ago
(26-Oct-2022)
1/4 (25%)
$6.75 (36.99%)
151
Buy
$11
3 years 4 months 10 days ago
(03-Jun-2022)
2/2 (100%)
$3.33 (40.64%)
1025
What is AGLE (Aeglea Bio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AGLE (Aeglea Bio Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AGLE (Aeglea Bio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most bullish on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most reserved on AGLE (Aeglea Bio Therapeutics)?
